DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 07 · Volume 111 · October 2003 DOI: 10.1055/s-002-2934

Review

  • 405
    Holstein, A.; Egberts, E.-H.:

    Risk of Hypoglycaemia with Oral Antidiabetic Agents in Patients with Type 2 Diabetes

    • Article

  • 415
    Vierhapper, H.; Heinze, G.; Gessl, A.; Exner, M.:

    Adrenocortical Tumors: Prevalence of Impaired Glucose Tolerance and of “Paradoxical Rise” of Cortisol During an Oral Glucose Tolerance Test

  • 421
    Geissler, A.; Fründ, R.; Schölmerich, J.; Feuerbach, S.; Zietz, B.:

    Alterations of Cerebral Metabolism in Patients with Diabetes Mellitus Studied by Proton Magnetic Resonance Spectroscopy

  • 428
    Hunger-Dathe, W.; Braun, A.; Müller, U. A.; Schiel, R.; Femerling, M.; Risse, A.:

    Insulin Pump Therapy in Patients with Type 1 Diabetes Mellitus: Results of the Nationwide Quality Circle in Germany (ASD) 1999 - 2000

  • 435
    Nolte, W.; Wirtz, M.; Rossbach, C.; Leonhardt, U.; Buchwald, A. B.; Scholz, K.-H.; Ramadori, G.:

    TIPS Implantation Raises Leptin Levels in Patients with Liver Cirrhosis

  • 443
    Bliesener, N.; Steckelbroeck, S.; Redel, L.; Klingmüller, D.:

    Dose Distribution in Hydrocortisone Replacement Therapy Has a Significant Influence on Urine Free Cortisol Excretion

    • Short Communication

  • 447
    Žofková, I.; Zajíčková, K.; Hill, M.; Křepelová, A.:

    Does Polymorphism C1377T of the Calcitonin Receptor Gene Determine Bone Mineral Density in Postmenopausal Women?